Background--Extracorporeal membrane oxygenation (ECMO) unloads the heart, providing a bridge to recovery in children after myocardial stunning. ECMO also induces stress which can adversely affect the ability to reload or wean the heart from the circuit. Metabolic impairments induced by altered loading and/or stress conditions may impact weaning. However, cardiac substrate and amino acid requirements upon weaning are unknown. We assessed the hypothesis that ventricular reloading with ECMO modulates both substrate entry into the citric acid cycle (CAC) and myocardial protein synthesis.
xtracorporeal membrane oxygenation (ECMO) offers a route to recovery after myocardial stunning and damage sustained during cardiovascular surgery in infants and children. 1 Approximately 2% to 5% of children undergoing surgery for congenital heart defects with cardiopulmonary bypass require subsequent support by ECMO. 2 Additional indications for cardiac support by ECMO include ventricular arrest and myocarditis. The majority of these patients undergoing ECMO for cardiac indications are infants and young children older than neonates and the Extracorporeal Life Support Organization (ELSO) database shows that these numbers are rising. 1 Veno-arterial ECMO for cardiac support unloads the ventricles, supports the systemic blood pressure, and maintains blood oxygenation. Adversely, ventricular volume unloading by the ECMO circuit promotes an inflammatory response, which disrupts hormonal homeostasis and induces metabolic stress. 3, 4 Despite these stresses, the immature heart maintains metabolic flexibility and protein synthesis under ECMO conditions. 5 However, weaning from ECMO reintroduces cardiac work requirements. Though many patients tolerate initial weaning, mortality in the subsequent 30 days remains high in part due to inability to adequately sustain cardiac output. 6 The myocardial energy requirements and metabolic shifts associated with weaning are unknown but may play an important role in determining cardiac functional recovery. Furthermore, appropriate nutritional support may be critical in maintaining cardiac function after weaning particularly in the immature heart, which must also sustain normal growth. Carbohydrates and fatty acids (FAs) represent the primary energy substrates used by the heart. However, to a lesser extent amino acids, which can be shuttled into protein synthesis, are also used as sources for ATP production in the citric acid cycle (CAC). 7 In fact, amino acids contribute carbons CAC intermediates both through oxidative pathways and anaplerosis. Thus, amino acids provide integration between oxidative metabolism and protein synthesis. The branched chain amino acid, leucine, in particular regulates protein turnover in the heart, 8 and also behaves as a ketogenic species broken down to acetylcoenzyme A (CoA) and acetoacetyl-CoA. We tested the hypothesis that ventricular reloading after ECMO increases energy requirements and modulates both substrate entry into the CAC and myocardial protein synthesis. Elucidation of these modifications could identify potential therapeutic targets for sustaining adequate cardiac function after weaning. In this study we used an established immature piglet model, which emulates ECMO and weaning in infants and children supported for cardiac indications. 5 We used 13-Carbon ( 13 C)-labeled substrates as well as nuclear magnetic resonance (NMR) and gas chromatography/mass spectroscopy (GC-MS) methods to track metabolism and protein synthesis.
Materials and Methods

Animal Models
Sixteen male Yorkshire piglets (body weight 7.8 to 15.6 kg, age 27 to 42 days) were used for the experiments and were divided into 2 groups based on ventricular loading status: 8 hours of ECMO (UNLOAD, n=6, 2 cases were excluded for coronary artery anomaly and severe anemia) and postwean from ECMO (RELOAD, n=8). They were fasted overnight with free access to water and were premedicated with an intramuscular injection of ketamine (33 mg/kg) and xylazine (2 mg/kg). After intubation through surgical tracheostomy, the piglets were mechanically ventilated with an oxygen and isoflurane (1% to 2%) mixture. All experimental procedures were approved by Seattle Children's Institutional Animal Use and Care Committee. After median sternotomy, a flow probe was placed around the ascending aorta to measure cardiac output (TS420, Transonic Systems Inc). A 5Fr high-fidelity micromanometer was used to measure pressure within the LV body via apex.
Coronary venous flow and myocardial oxygen consumption (MVO 2 ) were measured via a shunt created between the coronary sinus and the superior vena cava. 5, 9, 10 We used a miniaturized extracorporeal circuit consisting of a roller peristaltic pump console (Sarn8000 Terumo) and a hollow fiber membrane oxygenator (CX-RX05RW, Terumo Figure 1 ). 5 Methanol-extracted metabolites from tissue samples were also analyzed using 1 H-NMR. A standard 1-dimensional proton nuclear Overhauser effect spectroscopy (NOESY) with presaturation (TNNOESY) was collected on each sample, using the Chenomx standard data collection protocol 12 : a nonselective 90°excitation pulse (%7 ls at 53 dB), a mixing time of 100 ms, acquisition time of 4 seconds, a recycle delay of 1 second, a sweep width of 12 ppm, and temperature control set to 25°C. Collected spectra were analyzed using Chenomx software version 7.1 (Chenomx Inc), with quantifications based on spectral intensities relative to 0.5 mmol/L 2,2-dimethyl-2-silapentane-5-sulfonate, which was added as a spike to each sample.
Metabolic Analyses by Gas Chromatography-Mass Spectrometry (GC-MS)
GC-MS was performed to measure the 13 C-enrichment and concentrations of CAC intermediates, pyruvate, lactate and intracellular free leucine enrichment as described previously. 10, 13, 14 GC-MS data are reported as the 13 C-molar percent enrichment (MPE) and absolute quantity of each metabolite. A detailed description for the calculations of flux ratios has also been published previously. 5, 10, 11 Mass isotopomers of metabolites containing 1 to n 13 C-labeled atoms were identified as Mi, with i=1, 2, … n. The pathway from pyruvate entering into the CAC via acetyl-CoA is called pyruvate decarboxylation (PDC). PDC flux rate relative to citrate synthase (CS) was determined using the following formula:
PDC/CS ¼ðtotal MPE of citrate -total MPE of malateÞ =M1 of intracellular pyruvate;
where M1 is the 13 C-MPE in M1 isotopomers.
Absolute PDC flux rate was calculated using the stoichiometric relationship between myocardial oxygen consumption (MVO 2 ) and citrate formation from pyruvate. According to equations by Panchal et al and Vincent et al, 13 where t is the time of tracer incorporation, in hours (1 hour for all groups).
Statistical Analyses
Reported values are meansAEstandard error (SE) in figures, text, and tables. The statistical differences between 2 groups were determined using Mann-Whitney U test. Analyses of variance (ANOVA) for repeated measures were used where appropriate (eg, time related changes during ECMO in RELOAD). Significant differences from baseline value in Table 1 and Figure 2 in individual groups were estimated by paired t test if ANOVA indicated significant differences. Criterion for significance was P<0.05 for all comparisons.
Results
Cardiac Function
This study was designed to determine the metabolic shifts that were promoted with reloading after a period of unloading. The metabolic studies required termination of the animals with tissue extraction. Therefore, substrate oxidation and protein synthesis data from the 2 different conditions, ECMO and reloading, could not be obtained in individual animals. However, full set hemodynamic data at multiple time points were available in individual animals, which completed the protocol through reloading. The serial time data for UNLOAD and RELOAD in Table 1 show that unloading by ECMO markedly reduces the hemodynamic parameters. The systolic parameters in RELOAD are reestablished to approximate baseline values indicating successful weaning (WEAN). In particular the pulse pressure, an index of volume loading, is reduced by more than 70% by ECMO and reestablished with WEAN. Diastolic function or ventricular relaxation as indexed by minimum dP/dt was impaired at %60% baseline during reloading. The baseline data are similar for both experimental groups, and the UNLOAD hemodynamic data also illustrate that ECMO reduces all the hemodynamic parameters to a similar extent as occurs in the RELOAD group. Hemoglobin, as expected, is reduced by ECMO in both groups, but remains constant through weaning in the RELOAD as these animals did not receive any blood transfusions. Thus, the data establish that metabolic differences between UNLOAD and RELOAD are not caused by hemodynamic differences between the 2 experimental groups at baseline or during ECMO, but are elicited by the WEAN.
Myocardial Oxygen Consumption
Data in Figure 2 illustrate the oxygen cost for successful reloading and reestablishment of hemodynamic parameters, which are similar to baseline. ECMO induces a substantial reduction in MVO 2 largely due to a drop in O 2 extraction (A-V), which then remains constant over the term, as the ECMO circuit maintains coronary flow ( Figure 2B and 2C) . WEAN at hour 6 induces an abrupt and marked increase in MVO 2 in RELOAD secondary to an increase coronary blood flow with the reestablishment of normal circulation. The MVO 2 at WEAN then exceeds the baseline values by %35%. Substrate infusion over the final hour of the protocol did not lead to further change in MVO 2 . Thus the metabolic cost in terms of oxygen consumption %35% baseline value for successful reestablishment of systolic function, although accompanied by diastolic impairment.
RELOAD Alters Myocardial Energy Metabolism
The principal objective for this study was to determine the substrate preferences and oxidation rates associated with weaning after ECMO. Prior studies in this experimental model showed that ECMO alone altered FC for pyruvate and leucine or 13 C-MPE for the CAC intermediates when compared to control loading conditions under normal circulation. 5 The effect of RELOAD after ECMO on 13 C-NMR spectra is illustrated in Figure 3 , where the differences are apparent in the C5 complex between UNLOAD and RELOAD. The summarized data (Figure 4) show that RELOAD exhibits a near 50% reduction in FC-pyruvate along with a comparable increase in FC from endogenous unlabeled substrate. The relatively minor FC-leucine is similar between the 2 groups. Despite the lower FC-pyruvate in RELOAD, the GC-MS data show that the abundance of pyruvate within the myocardium is dramatically higher in RELOAD compared to UNLOAD along with the elevated pyruvate MPE ( Figure 5 ). Absolute lactate levels determined by both GC-MS ( Figure 5 ) and 1 H-NMR ( Figure 6 ) are lower in RELOAD, while the concentration for alanine, another potential product of pyruvate metabolism, is similar between the 2 groups. The PDC/CS ratio, an index of overall pyruvate flux through pyruvate dehydrogenase including labeled and unlabeled substrate and estimated by GC-MS, was substantially lower in RELOAD (18.8AE0.2%) compared to UNLOAD (33.3AE0.9%) ( Figure 4B ). Estimation of absolute PDC flux, calculated by MVO 2 and PDC/CS, showed no significant difference in RELOAD (0.24AE0.06 lmol/minute) compared to UNLOAD (0.21AE 0.04 lmol/minute) ( Figure 4C ). GC-MS demonstrated that RELOAD increased absolute levels of all measured CAC intermediates including citrate, a-ketoglutarate (a-KG), fumarate, and malate ( Figure 7A) 
RELOAD Alters Myocardial Protein Synthesis
Compared with UNLOAD, RELOAD significantly increased the 13 C-MPE of leucine (74.3AE5.8% versus 92.7AE1.4%, P<0.01) ( Figure 8A ). FSR substantially increased %2-fold with RELOAD ( Figure 8B ). As FC-leucine did not change with RELOAD (Figure 4 ), the data suggest that leucine is redirected into protein synthesis rather than oxidative metabolism. Further 1 H-NMR data supporting a shift in amino acid metabolism during RELOAD is shown in Figure 8C . Although the aspartate pool did not change and glutamate decreased by RELOAD, glutamine increased.
Discussion
This study describes the metabolic response promoted by weaning from the circuit in a model emulating clinical ECMO in infants and young children. In a previous study, we showed that ECMO lowered myocardial consumption, as expected, indicating a global decrease in overall oxidative metabolism, including amino acids, while metabolic flexibility was maintained. 5 In this study, we demonstrate that weaning from ECMO produces, as expected, an abrupt increase in cardiac work and MVO 2 , which was associated with shifts in substrate or pathways contribution to tissue pyruvate and acetyl-CoA formation, as well as to expansion in the CAC intermediate pool. The time-course of changes in MVO 2 (A), oxygen content in the coronary vessels (B), and coronary flow (C). MVO 2 was markedly decreased with ventricular unloading (*P<0.05 vs baseline), and increased more than baseline by RELOAD (*P<0.05 vs baseline). Substrate infusion itself did not lead to change MVO 2 . Moreover difference between arterial and venous oxygen content was significantly decreased during ECMO, whereas coronary flow was significantly increased by RELOAD (*P<0.05 vs baseline). Values are meansAESE; n=8. ECMO indicates extracorporeal membrane oxygenation; SE, standard error; A-V, difference between arterial and venous oxygen content.
in substrate preference during the reloading phase might also be responsible for these changes in MVO 2 , particularly as we observed decreased reliance on oxygen-efficient carbohydrate metabolism at the expense of endogenous sources, presumably FAs. The maintenance of [PCr]/[ATP] during this phase suggests that increased uncoupling of oxidative phosphorylation does not occur during reloading and is not responsible for the difference in MVO 2 between baseline and reloading.
Indeed, the labeling strategy used in our experiments produced complementary NMR and GC-MS data. 13 C-NMR data showed decreased FC-pyruvate, while GC-MS showed lower overall PDC/CS ratio and no elevation in the estimated absolute PDC flux during the abrupt work increase with RELOAD. These 2 complementary methods indicate that the substrate preference for acetyl-CoA formation shifts away from pyruvate dehydrogenase. Additionally, the large increases in total cardiac pyruvate level in conjunction with elevation in its 13 C-MPE suggest that glycolysis or other pathways contribute relatively less to pyruvate formation and PDC during reloading. Combined, these data indicate that alternative oxidative pathways provide the increase in acetyl-CoA supply to the CAC necessary for oxidation and the increase in cardiac work requirements during reloading. The labeling strategy for leucine also eliminated branched--chain amino acids as a potential acetyl-CoA source of energy for the increased work. Thus, through a process of elimination, our data suggest that FAs or ketones provide the oxidative source for meeting the increased energy -leucine into the left anterior descending coronary artery under UNLOAD and RELOAD conditions. The spectra show adequate signal to noise ratio for peak integration. Chemical shifts in parts per million (ppm) were as follows: C3, 27.7; C4, 34.2; C5 of glutamate, 182.2; [2-
13 C]-alanine, 51.9 and [2-
13 C] lactate, 69.2. Marked differences occur in glutamate peak complexes between the 2 conditions. C5 in RELOAD shows prominently increased doublet peak area (*), indicating increased leucine contribution or decreased pyruvate contribution, compared to UNLOAD. Additionally, the greater labeled lactate to alanine ratio can be observed in RELOAD. NMR inidcates nuclear magnetic resonance.
requirements. This contention is supported by the elevation of [NADH]/[NAD + ], previously associated with increased FA or ketone oxidation in the heart in vivo, 17, 18 as well as prior studies in swine, which showed that abrupt increases in cardiac energy expenditure caused by inotropic dobutamine stimulation are matched by ATP produced via free FA oxidation. 17 Further studies using 13 C-labeled free FAs are, however, required to prove this contention, and are currently being performed in our laboratory.
We also identified expansion of the CAC intermediate pool during ventricular reloading. Our prior studies using a similar immature pig model showed that under fully aerobic conditions pyruvate contributed to the CAC primarily through decarboxylation to acetyl-CoA versus anaplerotic carboxylation to oxaloacetate. 9 In this study, we did not assess flux through anaplerotic pyruvate carboxylation, but additional data provide evidence-albeit indirect-indicating that this pathway contributes carbon for the CAC expansion. Our previous study using our pig model showed that %20% to 25% of the pyruvate contribution to the CAC occurred through carboxylation during normal load conditions for LV. 9 This 4 carbon anaplerotic entry into the CAC occurs through reactions catalyzed by pyruvate carboxylase and/or malic enzyme. 19 Elevations in tissue concentration for pyruvate, as noted in our study, favor flux in these reactions relative to pyruvate dehydrogenase. 20 Prior studies performed in isolated rat hearts showed that FAs supplied in high concentration in perfusate inhibited pyruvate dehydrogenase and redirected pyruvate through carboxylation, and this was associated with an increase in tissue CAC intermediate level, principally citrate and malate as is observed in this study. 13 In addition, increased cardiac work by dobutamine stimulation in mature swine increased FA oxidation and also promoted anaplerotic flux from pyruvate. 17 Consistent with our findings, these perturbations, which increase FA oxidation and pyruvate anaplerosis, all promoted expansion of the CAC intermediate pool. Nevertheless, we cannot eliminate a reduction in metabolism of CAC intermediates through nonoxidative pathways as a potential mechanism for the pool expansion.
Limitations
Many of the advantages and limitations of this ECMO model and the 13 C isotopomer methods have been previously described in detail. 5, 9, 10 Our principal goal was to define the specific metabolic shifts which are associated with ventricular reloading in a clinical model. Of note, though cardiac systolic function successfully recovered during reloading, diastolic function exemplified by minimum dP/dt remains slightly impaired. It has been suggested that specific limbs of the Frank-Starling curve are more dependent on glucose metabolism than others. 21 Our current piglet model was subjected to metabolic and inflammatory stress induced by ECMO, 5 which can cause cardiac stunning and emulate some clinical scenarios such as failure to wean. We did not perform these experiments in a cardiac injury model, although damage caused by ischemia/reperfusion is a primary ECMO indication in the pediatric age group. 1 We also delivered supraphysiological intracoronary doses of 13 C-labeled substrates in order to assure acquisition of high-quality NMR and GC-MS data. Our prior studies indicated that these doses did not substantially elevate tissue levels for pyruvate and leucine. 5, 9 Myocardial pyruvate levels did rise substantially during reloading, probably due to the excess availability, and may have affected glucose utilization. Finally, leucine itself promotes protein synthesis in cardiomyocytes in vitro, 22 and at high-dose could potentially stimulate protein synthesis. Our data, reflecting the marked increase in protein synthesis with reloading, demonstrate the myocardial capacity to achieve even higher rates. Our studies show that the increased workload associated with weaning promoted a near doubling in the FSR. Although, the studies were not designed to determine the mechanism, the data indicate that reloading under these conditions promotes protein synthesis, which should be necessary for physiological growth in the immature heart. The clinical implications for expansion of the CAC intermediate pool remain unclear. Unlike our prior studies, 9 the labeling strategy was not specifically designed to determine the source of carbons for this expansion or whether these CAC changes related directly or indirectly to amino acid availability for protein synthesis. We did observe shifts in the glutamate/ glutamine pools. Glutamine, which was increased by reloading, is generally considered a promoter of protein synthesis. Interestingly, recent experiments in isolated perfused hearts show that glutamine also stimulates oxidation of FAs, 23 which we assume as the major alternate substrate in our model. 
Summary and Clinical Implications
Our study identifies metabolic perturbations as potential therapeutic targets for maintaining cardiac contractile function and protein synthesis after ECMO weaning. Specifically, our data show that substrate flux through PDC was not increased during reloading. Successful reestablishment of systolic cardiac function, as occurred in our study, relies on the heart's ability to optimally select substrates for oxidation and limitations in carbohydrate oxidation could adversely affect the ability to reload. Our prior studies showed that stimulating PDC flux through either pyruvate supplementation or with thyroid hormone improves cardiac function after ischemia-reperfusion injury in these immature pigs. 9, 10 Future studies are currently ongoing to determine whether these interventions would also be beneficial after ECMO weaning in an injury model.
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